Opaleye Management as of Dec. 31, 2017
Portfolio Holdings for Opaleye Management
Opaleye Management holds 35 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axogen (AXGN) | 17.9 | $56M | 2.0M | 28.30 | |
| Blueprint Medicines (BPMC) | 17.8 | $55M | 735k | 75.41 | |
| Fibrogen (FGEN) | 5.5 | $17M | 360k | 47.40 | |
| Loxo Oncology | 4.8 | $15M | 176k | 84.18 | |
| Immunomedics | 4.7 | $15M | 899k | 16.16 | |
| Codexis (CDXS) | 4.5 | $14M | 1.7M | 8.35 | |
| Xoma Corp Del (XOMA) | 3.6 | $11M | 320k | 35.60 | |
| Ablynx Nv | 3.4 | $11M | 420k | 24.99 | |
| Corium Intl | 3.3 | $10M | 1.1M | 9.61 | |
| Sangamo Biosciences (SGMO) | 3.0 | $9.5M | 580k | 16.40 | |
| Strongbridge Bioph shs usd | 2.9 | $9.1M | 1.3M | 7.25 | |
| Fennec Pharmaceuticals (FENC) | 2.7 | $8.5M | 847k | 10.02 | |
| Agios Pharmaceuticals (AGIO) | 2.4 | $7.4M | 130k | 57.17 | |
| Audentes Therapeutics | 2.1 | $6.7M | 210k | 31.68 | |
| Crispr Therapeutics (CRSP) | 2.1 | $6.6M | 281k | 23.48 | |
| Cymabay Therapeutics | 2.0 | $6.1M | 665k | 9.20 | |
| Ardelyx (ARDX) | 1.9 | $5.9M | 900k | 6.60 | |
| Foamix Pharmaceuticals | 1.9 | $5.8M | 960k | 6.01 | |
| Argenx Se (ARGX) | 1.8 | $5.6M | 89k | 63.13 | |
| Nektar Therapeutics (NKTR) | 1.5 | $4.8M | 80k | 59.71 | |
| Inotek Pharmaceuticals | 1.5 | $4.7M | 1.8M | 2.61 | |
| Acceleron Pharma | 1.4 | $4.3M | 102k | 42.43 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $4.2M | 90k | 46.38 | |
| Amarin Corporation (AMRN) | 1.1 | $3.4M | 860k | 4.01 | |
| Chimerix (CMRX) | 0.9 | $2.8M | 600k | 4.63 | |
| Dermira | 0.9 | $2.8M | 100k | 27.81 | |
| Viking Therapeutics (VKTX) | 0.6 | $2.0M | 481k | 4.06 | |
| Uniqure Nv (QURE) | 0.6 | $1.8M | 91k | 19.58 | |
| Quanterix Ord (QTRX) | 0.5 | $1.4M | 65k | 21.46 | |
| Achillion Pharmaceuticals | 0.4 | $1.3M | 440k | 2.88 | |
| Protalix BioTherapeutics | 0.4 | $1.2M | 1.8M | 0.66 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $1.1M | 38k | 29.06 | |
| Syros Pharmaceuticals | 0.2 | $720k | 74k | 9.72 | |
| Spectrum Pharmaceuticals | 0.2 | $587k | 31k | 18.94 | |
| Biolinerx Ltd-spons | 0.1 | $273k | 250k | 1.09 |
